Home
News

Latest News

Hexvix®/Cysview™ demonstrates long term benefit
12 May 2011
British Journal of Urology publishes paper on Hexvix®
Demonstrates significant reduction in recurrence of bladder cancer

23 Mar 2011
Bladder cancer: Photodynamic diagnosis can improve surgical outcome
30 Nov 2010
Photocure announces positive preliminary results from the Allumera™ consumer trial
Allumera™ shows significant improvements in appearance of skin compared to light

29 Nov 2010
Photocure signs agreement with Salix Pharmaceuticals for Lumacan™
20 Oct 2010
New publication on Hexvix® demonstrating that Hexvix® guided fluorescence cystoscopy reduces recurrence in patients with non-muscle invasive bladder cancer
05 Oct 2010
Photocure announces successful Phase II results for Cevira™
04 Oct 2010
Photocure establishes US subsidiary to build speciality dermatology business
04 Aug 2010
Photocure announces US approval of Cysview™ for detection of bladder cancer
30 May 2010
Photocure announces results from phase II study in acne with Visonac™
28 May 2010
Expert panel recommends the use of Hexvix®-cystoscopy
21 Apr 2010
Hexvix® receives reimbursement approval in Germany
13 Jan 2010
Photocure received positive response from FDA on the New Drug Application (NDA) for Hexvix® for detection of bladder cancer
31 Dec 2009
FDA Advisory Committee voted favourably to Hexvix® application in USA
18 Dec 2009
Photocure granted patent in Europe and Russia for Visonac™ in the treatment of acne
26 Nov 2009
Presentations held at Photocure ASA's Capital Markets Day
03 Nov 2009
Photocure divests Metvix® to Galderma for EUR 51 million
07 Oct 2009
Hexvix® cystoskopi finner mer kreft og gir mindre tilbakefall
11 Jun 2009
Hexvix® cystoscopy detects more cancer and reduces recurrence
11 Jun 2009